ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Conditions: Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Carcinoma Metastatic in the Bone; Stage IVB Prostate Cancer AJCC v8 Interventions: Drug: Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981; Biological: Nivolumab Sponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials